Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2021-07-28 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing them about the issuance of duplicate share certificates due to lost or misplaced original certificates. It references compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is a notification about share certificate replacement, not a financial report, management change, or other types of filings. It does not contain financial data, earnings, or governance information. This type of announcement is best classified under Regulatory Filings (RNS) as it is a regulatory compliance notification that does not fit other specific categories.
2021-07-28 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated 27th July 2021 from Wockhardt Limited, announcing a visit by the High Commissioner of India to their UK manufacturing facility and highlighting the success of their vaccine production partnership. It is a corporate announcement intended for stock exchanges (BSE and NSE) and does not contain financial statements, management discussion, or detailed financial data. It is not a report, transcript, or regulatory filing but a public relations communication. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-07-27 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains multiple excerpts of unaudited consolidated and standalone financial results for the quarter ended June 30, 2021, including detailed financial tables with income, profit/loss, and earnings per share data. It references Regulation 33 of the SEBI (Listing and Disclosure Requirements) Regulations, 2015, which governs quarterly financial reporting. The document also mentions that these results have been reviewed by the Audit Committee and approved by the Board of Directors, and that statutory auditors have carried out limited reviews. These characteristics are consistent with an Interim / Quarterly Report (IR). The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not just an announcement or summary, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2021-07-26 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a detailed disclosure under Regulation 31(2) and 31(3) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. It pertains to the release of pledge on equity shares held by promoters in Wockhardt Limited. The content includes extensive tabular data about share encumbrances, pledge releases, promoter shareholding, and related details. The document is addressed to stock exchanges and includes regulatory references specific to shareholding and encumbrance disclosures. There is no indication of financial statements, earnings data, management discussion, or audit information. The document is a regulatory disclosure about share encumbrance changes by promoters, which fits the category of Major Shareholding Notification (MRQ).
2021-07-23 English
Press Release
Regulatory Filings
2021-07-22 English
Financial Result Updates
Regulatory Filings
2021-07-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.